Purchases and Sales Made in Q4 2021 in Homology Medicines, Inc. (FIXX)
This table provides information about the institutional ownership of Homology Medicines, Inc. (FIXX) during Q4 2021. The information is specifically focused on institutions that hold shares of Homology Medicines, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2022
Q4 2021
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-144K- 62.11% |
$525K - $1.12M
|
88K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-162K- 63.54% |
$588K - $1.26M
|
92.7K
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-174K- 22.27% |
$634K - $1.36M
|
608K
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-369K- 31.94% |
$1.34M - $2.87M
|
787K
$0
|